China Patent Laws Lead Cancer Patients To Seek Illegal Indian Generics
This article was originally published in PharmAsia News
Executive Summary
China’s patent laws have developed a conundrum of sorts, with physicians prescribing drugs for cancer patients who then turn to unapproved copies of branded versions imported from India.